Clinical Trials Directory

Trials / Unknown

UnknownNCT04934605

Genotype-phenotype Correlation of SLC26A4 in CI Patients With EVA

A Genotype-phenotype Correlation of SLC26A4 Mutations in Cochlear-implanted Patients With Enlarged Vestibular Aqueduct

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
0 Years – 18 Years
Healthy volunteers
Not accepted

Summary

To explore the genotype-phenotype correlation of SLC26A4 mutations in cochlear-implanted patients with enlarged vestibular aqueduct.

Detailed description

Enlarged vestibular aqueduct (EVA) is one of the most common forms of inner ear malformation that cause sensorineural hearing loss (SNHL). Some patients with EVA present delayed, fluctuating, and progressive hearing loss, while the others are with congenital or sudden hearing loss. Cochlear implants (CI) have been widely used in patients with severe-profound SNHL. However, it is difficult to define the optimal timing of CI operations for patients with EVA. Mutations in SLC26A4 are known to be responsible for EVA. This study is to explore the genotype-phenotype correlation of SLC26A4 mutations in cochlear-implanted patients with EVA.

Conditions

Interventions

TypeNameDescription
PROCEDURECochlear implantationCochlear implantation

Timeline

Start date
2010-05-01
Primary completion
2021-05-01
Completion
2021-07-01
First posted
2021-06-22
Last updated
2021-06-22

Source: ClinicalTrials.gov record NCT04934605. Inclusion in this directory is not an endorsement.

Genotype-phenotype Correlation of SLC26A4 in CI Patients With EVA (NCT04934605) · Clinical Trials Directory